Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015;11(11):2582-98.
doi: 10.1080/21645515.2015.1055424. Epub 2015 Jul 24.

Hepatitis B and A vaccination in HIV-infected adults: A review

G Mena  1 , A L García-Basteiro  2   3 , J M Bayas  2   4
Affiliations
Review

Hepatitis B and A vaccination in HIV-infected adults: A review

G Mena et al. Hum Vaccin Immunother. 2015.

Abstract

Hepatitis B and A account for considerable morbidity and mortality worldwide. Immunization is the most effective means of preventing hepatitis B and A. However, the immune response to both hepatitis vaccines seems to be reduced in HIV-infected subjects. The aim of this review was to analyze the immunogenicity, safety, long-term protection and current recommendations of hepatitis B and A vaccination among HIV-infected adults. The factors most frequently associated with a deficient level of anti-HBs or IgG anti-HAV after vaccination are those related to immunosuppression (CD4 level and HIV RNA viral load) and to the frequency of administration and/or the amount of antigenic load per dose. The duration of the response to both HBV and HAV vaccines is associated with suppression of the viral load at vaccination and, in the case of HBV vaccination, with a higher level of antibodies after vaccination. In terms of safety, there is no evidence of more, or different, adverse effects compared with HIV-free individuals. Despite literature-based advice on the administration of alternative schedules, revaccination after the failure of primary vaccination, and the need for periodic re-evaluation of antibody levels, few firm recommendations are found in the leading guidelines.

Keywords: HIV; Hepatitis A; Hepatitis B; adults; liver infection; prevention; vaccination.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Search strategy and selection criteria of articles included in the review.
See this image and copyright information in PMC

References

    1. Smith CJ, Ryom L, Weber R, Morlat P, Pradier C, Reiss P, et al. . Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): A multicohort collaboration. Lancet 2014;384:241-8. - PubMed
    1. Centers for Disease Control and Prevention CDC CDC Features: World Hepatitis Day 2014 - July 28th CDC Features. Atlanta: CDC; 2014. [updated July 2014]; Available at: http://www.cdc.gov/Features/WorldHepatitisDay/
    1. Centers for Disease Control and Prevention (CDC) HIV and Viral Hepatitis Fact Sheet. Atlanta: CDC; 2013. [updated March 2014]; Available at: http://www.cdc.gov/hiv/pdf/library_factsheets_HIV_and_viral_Hepatitis.pdf
    1. World Health Organization Hepatitis A. Fact Sheet Nº328. Geneva: WHO; 2008. [updated June 2014]; Available at: http://www.who.int/mediacentre/factsheets/fs328/en/
    1. Ida S, Tachikawa N, Nakajima A, Daikoku M, Yano M, Kikuchi Y, et al. . Influence of human immunodeficiency virus type 1 infection on acute hepatitis A virus infection. Clin Infect Dis 2002;34:379-85. - PubMed

MeSH terms